Achieve Life Sciences, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Achieve Life Sciences, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales grew in 0 of the last 3 years; profit grew in 1 of 3. Less steady than 86% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-13.4×Operating cash was negative last year, while some debt falls due within a year.
Higher than 52% of Healthcare companies in United States.
Cash Cushion Ratio
+3%Cash, after subtracting all debt, equals 3% of its market value (net cash).
Lower than 62% of Healthcare companies in United States.
Tangible Assets Ratio
96%Of every $100 the company owns, $96 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 76% of Healthcare companies in United States.
Tangible Net Worth Ratio
92%Of every $100 of net worth, $92 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 74% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
Achieve Life Sciences, Inc. made a loss over the last year. Achieve Life Sciences, Inc. owes $1.08 for every $1 it owns. Achieve Life Sciences, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossAchieve Life Sciences, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-45.66Achieve Life Sciences, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$670 MThe total market value of all of Achieve Life Sciences, Inc.'s shares at today's price (share price × number of shares), larger than 59% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
NegativeAchieve Life Sciences, Inc.'s net worth is negative ($15 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Return on equity (ROE)
-845.0%Achieve Life Sciences, Inc. lost 845.0% of its shareholders' money over the last year, lower than 96% of Healthcare companies in United States.
Owes vs Owns
1.08×Achieve Life Sciences, Inc. owes $1.08 for every $1 it owns, so it owes more than it owns, higher than 89% of Healthcare companies in United States.
Dividend yield
NoneAchieve Life Sciences, Inc. does not currently pay a dividend.
Profit growth
LossAchieve Life Sciences, Inc. made a loss in each of the last two years.
Interest cover
Not coveredAchieve Life Sciences, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashAchieve Life Sciences, Inc. held $21 M more cash than debt (net cash) at Dec 2025.
Questions
What is Achieve Life Sciences, Inc.'s return on equity?
Achieve Life Sciences, Inc. lost 845.0% of its shareholders' money over the last year, lower than 96% of Healthcare companies in United States.
How much does Achieve Life Sciences, Inc. owe compared with what it owns?
Achieve Life Sciences, Inc. owes $1.08 for every $1 it owns, so it owes more than it owns, higher than 89% of Healthcare companies in United States.
Does Achieve Life Sciences, Inc. pay a dividend?
No. Achieve Life Sciences, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.